<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02699788</url>
  </required_header>
  <id_info>
    <org_study_id>TGH0006</org_study_id>
    <nct_id>NCT02699788</nct_id>
  </id_info>
  <brief_title>Emergency Department MCG for Suspected Acute Coronary Syndrome</brief_title>
  <official_title>Emergency Department MCG for Suspected Acute Coronary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampa General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampa General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to assess a new non-invasive computerized, multiphase, resting
      electrocardiogram analysis device in early identification of patients at risk for acute
      coronary syndrome. The overall objective is to assess the association between the results
      from a resting MCG and 30-day cardiovascular outcome in patients presenting to the emergency
      department with suspected coronary disease.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No patients enrolled, sponsor refused to pay site invoices.
  </why_stopped>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Actual">November 29, 2017</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of MCG as assessed by the development of major adverse cardiac events (MACE).</measure>
    <time_frame>30 days</time_frame>
    <description>MACE will be defined as the composite of cardiac death, myocardial infarction (MI), or coronary revascularization.
2.2 Seco11dary</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Multifunction Cardiogram</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>non-invasive computerized, multiphase, resting electrocardiogram analysis device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multifunction Cardiogram</intervention_name>
    <arm_group_label>Multifunction Cardiogram</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 and over.

          -  Symptoms consistent with a possible acute coronary syndrome per the treating emergency
             physician.

          -  Has an electrocardiogram performed while in the ED.

        Exclusion Criteria:

          -  Acute ST-segment elevation MI.

          -  Patient unable or unwilling to complete follow-up.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason Wilson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampa General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>February 1, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2016</study_first_posted>
  <last_update_submitted>September 9, 2019</last_update_submitted>
  <last_update_submitted_qc>September 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

